Hydromethylthionine enhancement of central cholinergic signalling is blocked by rivastigmine and memantine
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Neurochemistry"
DOI: 10.1111/jnc.15553
Abstract: The prevention of tau protein aggregations is a therapeutic goal for the treatment of Alzheimer's disease (AD), and hydromethylthionine (HMT) (also known as leucomethylthioninium‐mesylate [LMTM]), is a potent inhibitor of tau aggregation in vitro and… read more here.
Keywords: memantine; rivastigmine memantine; ach; hmt ... See more keywords